Mycotoxin Panel
A well-documented, focused urine mycotoxin panel with clear pricing, competitive ELISA methodology, 16 disclosed targets, and a short published turnaround. Its main limits are narrower coverage than larger panels and the need for careful clinical interpretation because urine detection does not establish a source or diagnosis.
Review status. This record is live for catalog testing, but its Test Grade and dimension scores are still awaiting editorial publication.
Mold exposure
The product page names the method, sample type, targets, price, and turnaround.
A urine result cannot identify where exposure occurred or prove that a toxin caused symptoms.